{"id":"https://openalex.org/W1997590635","doi":"https://doi.org/10.1177/2047487314544046","title":"Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial","display_name":"Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial","publication_year":2014,"publication_date":"2014-07-29","ids":{"openalex":"https://openalex.org/W1997590635","doi":"https://doi.org/10.1177/2047487314544046","mag":"1997590635","pmid":"https://pubmed.ncbi.nlm.nih.gov/25073857","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4385003"},"language":"en","primary_location":{"id":"doi:10.1177/2047487314544046","doi":"https://doi.org/10.1177/2047487314544046","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2047487314544046","pdf_url":"https://academic.oup.com/eurjpc/article-pdf/23/1/50/34274517/eurjpc0050.pdf","source":{"id":"https://openalex.org/S201064403","display_name":"European Journal of Preventive Cardiology","issn_l":"2047-4873","issn":["2047-4873","2047-4881"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Preventive Cardiology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/eurjpc/article-pdf/23/1/50/34274517/eurjpc0050.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089890051","display_name":"Robert A. Wolk","orcid":"https://orcid.org/0000-0001-8581-6647","observed_orcids":["https://orcid.org/0000-0001-8581-6647"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert Wolk","raw_affiliation_strings":["Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, USA","Pfizer Global Research &amp; Development, Pfizer Inc., Groton, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, USA","institution_ids":["https://openalex.org/I1330342723"]},{"raw_affiliation_string":"Pfizer Global Research &amp; Development, Pfizer Inc., Groton, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045145969","display_name":"Marnie H. Bertolet","orcid":"https://orcid.org/0000-0002-5799-9033","observed_orcids":["https://orcid.org/0000-0002-5799-9033"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marnie Bertolet","raw_affiliation_strings":["University of Pittsburgh, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008504819","display_name":"Maria M. Brooks","orcid":"https://orcid.org/0000-0002-2030-7873","observed_orcids":["https://orcid.org/0000-0002-2030-7873"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria M Brooks","raw_affiliation_strings":["University of Pittsburgh, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059098934","display_name":"Richard E. Pratley","orcid":"https://orcid.org/0000-0002-2912-1389","observed_orcids":["https://orcid.org/0000-0002-2912-1389"]},"institutions":[{"id":"https://openalex.org/I4405270336","display_name":"AdventHealth","ror":"https://ror.org/00gqase94","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4405270336"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard E Pratley","raw_affiliation_strings":["Florida Hospital Diabetes and Translational Research Institutes, Orlando, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Florida Hospital Diabetes and Translational Research Institutes, Orlando, USA","institution_ids":["https://openalex.org/I4405270336"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112384262","display_name":"Burton E. Sobel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111236770","display_name":"University of Vermont","ror":"https://ror.org/0155zta11","country_code":"US","type":"education","lineage":["https://openalex.org/I111236770"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Burton E Sobel","raw_affiliation_strings":["University of Vermont, Burlington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Vermont, Burlington, USA","institution_ids":["https://openalex.org/I111236770"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073676650","display_name":"Robert L. Frye","orcid":"https://orcid.org/0000-0002-4060-324X","observed_orcids":["https://orcid.org/0000-0002-4060-324X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert L Frye","raw_affiliation_strings":["Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072679208","display_name":"Prachi Singh","orcid":"https://orcid.org/0000-0002-7392-9035","observed_orcids":["https://orcid.org/0000-0002-7392-9035","https://orcid.org/0000-0003-4586-178X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Prachi Singh","raw_affiliation_strings":["Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057916451","display_name":"Andrew D. Calvin","orcid":"https://orcid.org/0000-0002-0469-2847","observed_orcids":["https://orcid.org/0000-0002-0469-2847"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew D Calvin","raw_affiliation_strings":["Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044466332","display_name":"Martin K. Rutter","orcid":"https://orcid.org/0000-0001-6380-539X","observed_orcids":["https://orcid.org/0000-0001-6380-539X"]},"institutions":[{"id":"https://openalex.org/I2799725268","display_name":"Manchester Academic Health Science Centre","ror":"https://ror.org/04rrkhs81","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2799725268"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Martin K Rutter","raw_affiliation_strings":["Endocrinology and Diabetes Research Group, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, UK","Manchester Diabetes Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Endocrinology and Diabetes Research Group, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, UK","institution_ids":["https://openalex.org/I28407311"]},{"raw_affiliation_string":"Manchester Diabetes Centre, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, UK","institution_ids":["https://openalex.org/I2799725268"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075060708","display_name":"Arshag D. Mooradian","orcid":"https://orcid.org/0000-0002-8177-7668","observed_orcids":["https://orcid.org/0000-0002-8177-7668"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arshag D Mooradian","raw_affiliation_strings":["Division of Endocrinology, Diabetes and Metabolism, College of Medicine\u2013Jacksonville, University of Florida, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Endocrinology, Diabetes and Metabolism, College of Medicine\u2013Jacksonville, University of Florida, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084645609","display_name":"Virend Kristen Somers","orcid":"https://orcid.org/0000-0003-4045-4341","observed_orcids":["https://orcid.org/0000-0003-4045-4341"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Virend K Somers","raw_affiliation_strings":["Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic, Rochester, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":null,"display_name":"for the BARI 2D study group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"for the BARI 2D study group","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5089890051"],"corresponding_institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I180857899"],"apc_list":{"value":3355,"currency":"EUR","value_usd":3792},"apc_paid":null,"fwci":1.2584,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.79181415,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"23","issue":"1","first_page":"50","last_page":"58"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12979","display_name":"Cardiovascular Disease and Adiposity","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/insulin-sensitization","display_name":"insulin sensitization","score":0.9440000057220459},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.878000020980835},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":1.0},{"id":"https://openalex.org/keywords/adipokines","display_name":"adipokines","score":0.9900000095367432},{"id":"https://openalex.org/keywords/leptin","display_name":"leptin","score":0.9259999990463257},{"id":"https://openalex.org/keywords/adiponectin","display_name":"adiponectin","score":1.0},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.8709999918937683},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.9909999966621399},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.7710000276565552},{"id":"https://openalex.org/keywords/bari-2d-trial","display_name":"BARI 2D trial","score":0.8370000123977661},{"id":"https://openalex.org/keywords/revascularization","display_name":"revascularization","score":0.625}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9815222024917603},{"id":"https://openalex.org/C194832188","wikidata":"https://www.wikidata.org/wiki/Q2638593","display_name":"Adipokine","level":4,"score":0.8307733535766602},{"id":"https://openalex.org/C2778213512","wikidata":"https://www.wikidata.org/wiki/Q844935","display_name":"Coronary artery disease","level":2,"score":0.7305938601493835},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.656822919845581},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6244679689407349},{"id":"https://openalex.org/C2776217527","wikidata":"https://www.wikidata.org/wiki/Q944828","display_name":"Sensitization","level":2,"score":0.6075878739356995},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5781481266021729},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5128052830696106},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.44263720512390137},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33144068717956543},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.26722604036331177},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20102643966674805}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003324","descriptor_name":"Coronary Artery Disease","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003324","descriptor_name":"Coronary Artery Disease","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003324","descriptor_name":"Coronary Artery Disease","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018836","descriptor_name":"Inflammation Mediators","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D054392","descriptor_name":"Adipokines","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1177/2047487314544046","doi":"https://doi.org/10.1177/2047487314544046","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2047487314544046","pdf_url":"https://academic.oup.com/eurjpc/article-pdf/23/1/50/34274517/eurjpc0050.pdf","source":{"id":"https://openalex.org/S201064403","display_name":"European Journal of Preventive Cardiology","issn_l":"2047-4873","issn":["2047-4873","2047-4881"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Preventive Cardiology","raw_type":"journal-article"},{"id":"pmid:25073857","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25073857","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of preventive cardiology","raw_type":"Comparative Study"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/b63c8dea-f883-46aa-bf68-2823795f6000","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/b63c8dea-f883-46aa-bf68-2823795f6000","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Wolk, R, Bertolet, M, Brooks, M M, Pratley, R E, Sobel, B E, Frye, R L, Singh, P, Calvin, A D, Rutter, M K, Mooradian, A D & Somers, V K 2014, 'Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial', Eur J Prev Cardiol. https://doi.org/10.1177/2047487314544046","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:europepmc.org:4099801","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4385003","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4385003","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4385003","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Eur J Prev Cardiol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1177/2047487314544046","doi":"https://doi.org/10.1177/2047487314544046","is_oa":true,"landing_page_url":"https://doi.org/10.1177/2047487314544046","pdf_url":"https://academic.oup.com/eurjpc/article-pdf/23/1/50/34274517/eurjpc0050.pdf","source":{"id":"https://openalex.org/S201064403","display_name":"European Journal of Preventive Cardiology","issn_l":"2047-4873","issn":["2047-4873","2047-4881"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Preventive Cardiology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1979584133","display_name":"Together: Transforming and Translating Discovery to Improve Health","funder_award_id":"UL1TR001427","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G3015807127","display_name":"Mayo Clinic Center for Clinical and Translational Science (CCaTS)","funder_award_id":"UL1TR000135","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G3070200555","display_name":null,"funder_award_id":"HL061744","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G404290351","display_name":"BARI II - FIBRINOLYSIS AND COAGULATION CORE","funder_award_id":"U01HL063804","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G5487198344","display_name":"ECONOMIC OUTCOMES OF TREATMENT STRATEGIES IN BAR1-2","funder_award_id":"U01HL061748","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G6308196230","display_name":"Adipokines and Cardiovascular Disease in Diabetes","funder_award_id":"R01HL087214","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G6423313610","display_name":"BARI II: A TRIAL OF REVASC. & GLYCEMIC CONTROL IN NIDDM","funder_award_id":"U01HL061744","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G6517292598","display_name":"Treatment and Risk Factor Determinants of Cardiovascular Outcomes in BARI 2D","funder_award_id":"R21HL121495","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G7193548140","display_name":"BARI II GRANT PROPOSAL FOR ECG CORE LABORATORY","funder_award_id":"U01HL061746","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"}],"funders":[{"id":"https://openalex.org/F4320306493","display_name":"Abbott Laboratories","ror":"https://ror.org/0052svj16"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307769","display_name":"Astellas Pharma US","ror":"https://ror.org/05pw69n24"},{"id":"https://openalex.org/F4320310388","display_name":"Novartis Pharmaceuticals Corporation","ror":"https://ror.org/028fhxy95"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1997590635.pdf","grobid_xml":"https://content.openalex.org/works/W1997590635.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1978590803","https://openalex.org/W1985055917","https://openalex.org/W1997571115","https://openalex.org/W2009033372","https://openalex.org/W2013077255","https://openalex.org/W2017443146","https://openalex.org/W2021523302","https://openalex.org/W2022036486","https://openalex.org/W2045965545","https://openalex.org/W2051625732","https://openalex.org/W2067096633","https://openalex.org/W2067504868","https://openalex.org/W2077738040","https://openalex.org/W2086365883","https://openalex.org/W2086773481","https://openalex.org/W2096660073","https://openalex.org/W2097794068","https://openalex.org/W2106229125","https://openalex.org/W2110173826","https://openalex.org/W2111876001","https://openalex.org/W2113114548","https://openalex.org/W2131541226","https://openalex.org/W2131702141","https://openalex.org/W2136024338","https://openalex.org/W2141600407","https://openalex.org/W2143351663","https://openalex.org/W2147098206","https://openalex.org/W2165951067","https://openalex.org/W2166612659","https://openalex.org/W2169226612","https://openalex.org/W2172193326","https://openalex.org/W3171954256"],"related_works":["https://openalex.org/W2022036486","https://openalex.org/W2914334519","https://openalex.org/W2377000359","https://openalex.org/W7100897390","https://openalex.org/W1972033351","https://openalex.org/W2411744727","https://openalex.org/W2136491667","https://openalex.org/W2085516085","https://openalex.org/W2214431028","https://openalex.org/W2074175997"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"determine":[2],"the":[3,33,174,180,189,232],"effects":[4,113,205],"of":[5,81],"insulin":[6,10],"sensitization":[7],"(IS)":[8],"and":[9,28,59,92,99,103,160,199,208,218],"provision":[11],"(IP)":[12],"treatment":[13,74,105,201,224,234],"strategies":[14,75,106,202],"on":[15,206],"adipokines":[16],"associated":[17],"with":[18,23,54,213],"cardiovascular":[19,237],"disease":[20,31,62],"in":[21,32,47,52,76,156,179,188,211],"patients":[22,53,212],"type":[24,55,214],"2":[25,38,56,215],"diabetes":[26,57,216],"mellitus":[27,58,217],"coronary":[29,60,219],"artery":[30,61,220],"Bypass":[34],"Angioplasty":[35],"Revascularization":[36],"Investigation":[37],"Diabetes":[39],"trial":[40],"(BARI":[41],"2D).":[42],"METHODS":[43],"AND":[44],"RESULTS:":[45],"Changes":[46,155],"adipokine":[48,207],"levels":[49],"were":[50,95,164],"compared":[51],"randomized":[63],"to":[64],"IS":[65,102,181,198,223],"(n":[66,71],"=":[67,72,120,139,153,194],"1037)":[68],"versus":[69],"IP":[70,104,190,200,233],"1019)":[73],"BARI":[77],"2D.":[78],"Circulating":[79],"concentrations":[80],"leptin,":[82],"adiponectin,":[83],"monocyte":[84,157],"chemoattractant":[85,158],"protein-1,":[86],"tumor":[87,161],"necrosis":[88,162],"factor-alpha,":[89],"interleukin":[90,141],"6":[91,142],"C-reactive":[93,170],"protein":[94,171],"evaluated":[96],"at":[97],"baseline":[98],"one":[100],"year.":[101],"exerted":[107,203],"significant":[108],"(p":[109],"<":[110,126,133,147,185],"0.0001)":[111,186],"differential":[112],"on:":[114],"leptin":[115],"(IS:":[116,129,143],"0.02%":[117],"decrease,":[118,145],"p":[119,125,132,138,146,152,184,193],"0.01;":[121],"IP:":[122,135,149],"13%":[123],"increase,":[124,131],"0.0001);":[127],"adiponectin":[128],"73%":[130],"0.0001;":[134,148],"no":[136,150],"change,":[137,151],"0.52);":[140],"14%":[144],"0.68).":[154],"protein-1":[159],"factor-alpha":[163],"not":[165],"statistically":[166],"different":[167],"between":[168],"groups.":[169],"decreased,":[172],"but":[173],"effect":[175],"was":[176],"significantly":[177],"greater":[178],"group":[182,191],"(-32%,":[183],"than":[187,231],"(-5%,":[192],"0.0005).":[195],"CONCLUSION:":[196],"The":[197,222],"divergent":[204],"inflammatory":[209],"profile":[210],"disease.":[221],"strategy-induced":[225],"changes":[226],"may":[227],"be":[228],"more":[229],"favorable":[230],"strategy":[235],"regarding":[236],"pathophysiology.":[238]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}